Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

SCIT Versus TAR for Outpatients With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03446703
Recruitment Status : Completed
First Posted : February 27, 2018
Last Update Posted : February 27, 2018
Sponsor:
Information provided by (Responsible Party):
Guillermo Lahera, University of Alcala

Brief Summary:
The present work consists of a randomized clinical trial comparing the effectiveness of two interventions based on social cognition training in outpatients with schizophrenia. The investigators sought to compare the effect of a "targeted" (TAR) and a "broad-based" (SCIT) intervention on schizophrenia patients' performance in facial affect recognition, theory of mind and attributional style. Secondarily, the investigators compare the effect on symptomatology, general cognition and functioning. The main hypothesis was that the patient group receiving TAR would exhibit a greater improvement in emotion recognition performance at the post-intervention assessment in comparison to patients receiving the SCIT, and, conversely, patients receiving SCIT would show more effect in ToM and attributional style. To assess the durability of these effects, performance in measures of social cognition, basic cognitive functioning, symptomatology and functional capacity were assessed before (T0), after treatment (T1) and 3 months later (T2).

Condition or disease Intervention/treatment Phase
Schizophrenia Behavioral: SCIT Behavioral: TAR Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: A randomized three group pre-post design will be used to investigate effects of the Training of Affect Recognition (TAR), compared to the Social Cognition and Interaction Training (SCIT). Performance in social cognition measures, basic cognitive functioning symptomatology and functional capacity will be assessed before (T0), after (T1) treatment and (T2) 3 months later.
Masking: Single (Outcomes Assessor)
Masking Description: Trained raters who were blind to treatment condition assessed participants on the following variables at baseline, post-treatment and 3-month follow-up
Primary Purpose: Treatment
Official Title: Comparative Effectiveness of Social Cognition and Interaction Training Program (SCIT) Versus Training of Affect Recognition Program (TAR) for Outpatients With Schizophrenia.
Actual Study Start Date : September 1, 2013
Actual Primary Completion Date : October 1, 2016
Actual Study Completion Date : June 30, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia

Arm Intervention/treatment
Experimental: SCIT Social cognition interactive
Psychosocial intervention based on the Spanish translation of the original SCIT (Social Cognition and Interaction Training) instruction manual (Combs & Penn; Lahera & Benito, in press).
Behavioral: SCIT
SCIT is a 18 weekly sessions lasting 45-60 minutes per session. The group will include 8-12 patients, with 2 therapists. The content of the sessions is based on the Spanish translation of the original SCIT (Social Cognition and Interaction Training) instruction manual (Combs, Adams, et al., 2007); (G. Lahera et al., 2013). The manual of the program developed for the improvement of emotional perception skills, attributional style and theory of mind in people with schizophrenia.

Active Comparator: TAR Training in affect recognition
Training in Affect Recognition it is a 12-session training on facial affect recognition over a period of 6 weeks.
Behavioral: TAR
TAR is a 12-session training on facial affect recognition over a period of 6 weeks. Treatment includes one therapist (psychiatrist or clinical psychologist) and 2 patients. It involves neuropsychological strategies, such as restitution and compensation, as well as principles of errorless learning, direct positive reinforcement, verbalization and self-instruction (Frommann et al., 2003; Wölwer et al., 2005).




Primary Outcome Measures :
  1. Face emotion recognition [ Time Frame: 24 weeks ]
    Emotion recognition was measured with the Penn Emotion Recognition-40 (ER40) task, in which participants are asked to judge, one at a time, which emotion is shown on a series of 40 faces (Kohler et al, 2003).


Secondary Outcome Measures :
  1. Theory of Mind [ Time Frame: 24 weeks ]
    Theory of Mind was assessed with the Spanish version of the Hinting Task (Corcoran et al., 1995; Gil et al., 2012), consisting of 10 brief vignettes containing social hints that the respondent must interpret. Trials are scored from 0 to 2, with higher scores indicating better performance.

  2. Attributional Style [ Time Frame: 24 weeks ]
    Attributional Style was assessed using the Ambiguous Intentions Hostility Questionnaire (AIHQ, Combs et al., 2007). Scored vignettes consist of situations in which the intentions of the vignette characters are ambiguous. Participants are asked to rate on a Likert scale why they think the protagonist acts this way (AIHQHB subscale, Hostility Bias), whether the other person performed the action on purpose (AIHQIS sub- scale, Intentionality score) and how much they would blame him/her (AIHQBS subscale, Blame score). Likewise, they rate how angry the situation would make them feel (AIHQAS, Anger score) and how they would respond to this situation (AIHQAB, Aggressivity Bias). Higher scores reflect more hostile, negative, personal, and aggressive attributions.

  3. Functioning [ Time Frame: 24 weeks ]
    Global functioning was meausured by the Personal and Social Performance scale (PSP) PSP (Morosini et al, 2000; Spanish validation García-Portilla et al, 2012): it is a brief. Clinician-rated, reliable, valid and sensitive instrument for measuring functioning in outpatients with schizophrenia. After a structured interview, clinicians score 4 domains following the stablished criteria using a Likert scale from 1 (absence of functional impairment) to 6 (severe).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Outpatients who met DSM-IV criteria for schizophrenia and schizoaffective disorder (SCID-P; First et al. 1994)
  • Clinical stability: without any psychiatric hospitalizations in the last 3 months, with the same antipsychotic medication during the previous 6 weeks, and no planned change in the drug regime for the next 3 months.
  • Age in the range from 18 to 65 years

Exclusion Criteria:

  1. Disorders other than schizophrenia or schizoaffective disorder, according to DSM-IV diagnosis criteria;
  2. Additional axis-I or axis-II diagnosis;
  3. Dependence to alcohol or other drugs (except nicotine);
  4. Serious somatic disorders or organic brain damage;
  5. Mental retardation or difficulty speaking or understanding the Spanish language.
Layout table for additonal information
Responsible Party: Guillermo Lahera, M.D., Ph.D. Assistant Professor of Psychiatry, University of Alcala
ClinicalTrials.gov Identifier: NCT03446703    
Other Study ID Numbers: SCIT-TAR2017
First Posted: February 27, 2018    Key Record Dates
Last Update Posted: February 27, 2018
Last Verified: February 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Guillermo Lahera, University of Alcala:
social cognition
psychotherapy
rehabilitation
theory of mind
Additional relevant MeSH terms:
Layout table for MeSH terms
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders